Chemed Corporation (CHE)
- Previous Close
604.17 - Open
604.08 - Bid 239.28 x 900
- Ask 599.71 x 800
- Day's Range
595.69 - 605.51 - 52 Week Range
492.84 - 654.62 - Volume
68,209 - Avg. Volume
79,472 - Market Cap (intraday)
9.043B - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
33.30 - EPS (TTM)
17.94 - Earnings Date Apr 24, 2024
- Forward Dividend & Yield 1.60 (0.26%)
- Ex-Dividend Date Feb 23, 2024
- 1y Target Est
690.00
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
www.chemed.com15,087
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CHE
Performance Overview: CHE
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHE
Valuation Measures
Market Cap
9.04B
Enterprise Value
8.93B
Trailing P/E
33.32
Forward P/E
25.38
PEG Ratio (5yr expected)
2.54
Price/Sales (ttm)
4.01
Price/Book (mrq)
8.16
Enterprise Value/Revenue
3.95
Enterprise Value/EBITDA
21.56
Financial Highlights
Profitability and Income Statement
Profit Margin
12.03%
Return on Assets (ttm)
13.78%
Return on Equity (ttm)
28.59%
Revenue (ttm)
2.26B
Net Income Avi to Common (ttm)
272.51M
Diluted EPS (ttm)
17.94
Balance Sheet and Cash Flow
Total Cash (mrq)
263.96M
Total Debt/Equity (mrq)
12.58%
Levered Free Cash Flow (ttm)
239.52M
Research Analysis: CHE
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: CHE
CHE: Lowering target price to $640.00
CHEMED CORP has an Investment Rating of HOLD; a target price of $640.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetCHE: Lowering target price to $656.00
CHEMED CORP has an Investment Rating of HOLD; a target price of $656.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetCHE: Lowering target price to $669.00
CHEMED CORP has an Investment Rating of HOLD; a target price of $669.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetCHE: Lowering target price to $670.00
CHEMED CORP has an Investment Rating of HOLD; a target price of $670.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice Target